semaglutide patent expiry us Off-patent in 2026: the next revolution in anti-obesity medications Semaglutide Patent Expiration in India:
Description
If you work in nutrition, food science, public health, quality control, HACCP, or wellness, this is a moment worth discussing
Tirzepatide, with its dual GLP-1 and GIP action, seems to show the highest weight loss potential, though it is still under evaluation
However, the plan types affected were random, so this effect is more likely due to confounding variables
)
If future trials continue to confirm these results, retatrutide could become one of the most important therapies for obesity and metabolic disease
Semaglutide is also included in the next round of Medicare drug price negotiations under the Inflation Reduction Act, which Biden signed into law in 2022
